LCIFS to launch new sub-fund to invest into medical cannabis
Luxburg Carolath Investments Fund SICAV – a thrilling investment solution for the qualified investor.
The Luxburg Carolath Investments Fund SICAV is an investment company with variable capital pursuant to the laws of Liechtenstein. It is structured as an umbrella fund with several sub-funds that act as independent structures and follow different investment strategies.
Professional investors can co-invest in unique opportunities developed by Luxburg Carolath Group’s distinguished asset management or profit from the SICAV’s existing structures to implement their own investment ideas.
LCIFS is proud to announce a unique investment opportunity. Professional investors will soon be able to co-invest into a popular topic: the pharmaceutical and recreational cannabis market.
The essence of the investment idea of the new fund is to invest into carefully chosen targets along the cannabis supply chain to increase return multiples without the limitations of an integrated approach.
The cannabis industry is heading into a period marked by widespread legalisation, innovation, and considerable economic growth. With a projected value of €58bn by 2027 the market offers enormous growth potential for early movers. The market has professionalised and financialised to become a multi-faceted business with investment opportunities in production (cannabis growers), distribution (development, production and distribution of medical or recreational products) or ancillary services (providers of products and services to the cannabis industry).